Shareholders That Lost Money on Kyverna Therapeutics, Inc. (KYTX) Should Contact Levi & Korsinsky about Pending Class Action - KYTX
New York, New York--(Newsfile Corp. - January 2, 2025) - Levi & Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. ("Kyverna Therapeutics, Inc." or the "Company") (NASDAQ: KYTX) of a class...
September S&P 500 E-Mini futures (ESU24) are trending up +0.12% this morning as market participants looked ahead to key U.S. retail sales data and quarterly reports from more big banks.
Nasdaq Beats Q1 Revenue Estimates with Strong FinTech and Index Performance
Nasdaq (NDAQ) reported a strong first quarter, surpassing revenue expectations with significant contributions from its financial technology and index businesses. The company's financial technology unit...
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
The market's excited for these stocks, but there's no rush to buy them.